Prabir Roy-Chaudhury, MD, PhD, professor of medicine, was a co-investigator in a recent study that may lead to improved care for dialysis patients.
In the clinical trial, investigational devices, used to create more precise vascular access connections for hemodialysis, were implanted in 10 patients requiring new arteriovenous fistulas, which connect the artery and the vein directly in dialysis patients.
The device was successfully implanted and caused no adverse effects for all patients at the 42 day mark; nine out of 10 maintained opened arteries.
“Over 350,000 U.S. residents undergo chronic dialysis treatment yearly,” says Roy-Chaudhury. “Over 50 percent of arteriovenous fistulae are unsuitable after five months, primarily due to stenosis, or narrowing of the veins.
These preliminary findings could suggest a way to improve arteriovenous fistula maturation rates, improving the quality of care for patients.”